ETS1 and breast cancer: Next, RIP assay was performed, and it showed that miR-338-3p and ETS1 mRNA were enriched in Anti-Ago2 group compared with Anti-IgG group, suggesting that miR-338-3p could interact with ETS1 mRNA in BC cells (Figure 4(d)).